Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


INTERVIEW: Evotec CEO On Tears, Transparency And Trying Again

Executive Summary

Werner Lanthaler talks to Jo Shorthouse about partnering with big pharma on drug discovery, remaining authentic, and creating the 'half pregnant' company that Evotec is today.


Related Content

Evotec Seals Deal With Pfizer In Tissue Fibrosis
Further Sanofi Deals Move Evotec On From Development Setbacks
Roche/Evotec's Alzheimer's candidate fails
Evotec sues Andromeda after DiaPep277 deception


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts